Crystalys Therapeutics Doses First Patients in New Phase 2 Trial of Dotinurad for Difficult-to-Treat Gout

Yahoo Finance·May 26

This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.